Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Microneedles can precisely deliver cancer treatments with fewer side effects.

Biological therapy boosts the immune system to effectively fight melanoma.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Controlling immune responses with biomaterials can reduce scarring and improve skin regeneration.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

FK506 may stimulate hair growth when applied to the skin.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

New cytokine-targeted therapies show promise for treating alopecia areata.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Inflammation helps stem cells repair tissue by directing their behavior.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.